NextCure, Inc. — Form 8-K
Filed September 3, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
NextCure (tenant) and ARE-8000/9000/10000 Virginia Manor LLC (landlord) executed a Ninth Amendment on August 28, 2026, accelerating lease termination from March 31, 2030 to December 31, 2027 (or earlier via landlord's 3-business-day termination right). NextCure paid $758,648 lump sum and forfeited $39,292.70 security deposit; all future rent obligations cease September 1, 2026. The 29,864 sq ft Beltsville, Maryland facility (leased since January 2019) is being vacated with minimal obligations except environmental decommissioning report by September 15, 2026.
Why this rating
Exit cost (~$798k) represents 6.3% of company's $12.6M market cap—material. Early departure suggests cash constraints or operational contraction, raising going-concern questions for a $12.6M biotech.
Tradability signal
NO TRADE
No trade: only ~$67k traded in the last 30 min — too illiquid to enter and exit.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $7.84 ▲ 0.00% | at our read · unknown $7.84 | +10 min · unknown $7.84 ▲ 0.00% | +30 min · unknown $7.84 ▲ 0.00% | +1 hr · unknown $7.84 ▲ 0.00% | +4 hrs pending |
The stock had already moved +0.00% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; sessions other than regular hours are labeled. Not investment advice. How accurate are our calls? →
See more from September 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.